These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16113546)

  • 1. On-demand therapy with pantoprazole 20 mg as effective long-term management of reflux disease in patients with mild GERD: the ORION trial.
    Scholten T; Dekkers CP; Schütze K; Körner T; Bohuschke M; Gatz G
    Digestion; 2005; 72(2-3):76-85. PubMed ID: 16113546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
    van Zyl J; van Rensburg C; Vieweg W; Fischer R
    Digestion; 2004; 70(1):61-9. PubMed ID: 15297779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pantoprazole 20 mg on demand is effective in the long-term management of patients with mild gastro-oesophageal reflux disease.
    Kaspari S; Kupcinskas L; Heinze H; Berghöfer P
    Eur J Gastroenterol Hepatol; 2005 Sep; 17(9):935-41. PubMed ID: 16093871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D; Paré P; Pericak D; Pyzyk M;
    Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis.
    Bochenek WJ; Mack ME; Fraga PD; Metz DC
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1105-14. PubMed ID: 15569113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral pantoprazole for erosive esophagitis: a placebo-controlled, randomized clinical trial. Pantoprazole US GERD Study Group.
    Richter JE; Bochenek W
    Am J Gastroenterol; 2000 Nov; 95(11):3071-80. PubMed ID: 11095320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, placebo-controlled trial with single-dose pantoprazole for laryngopharyngeal reflux.
    Wo JM; Koopman J; Harrell SP; Parker K; Winstead W; Lentsch E
    Am J Gastroenterol; 2006 Sep; 101(9):1972-8; quiz 2169. PubMed ID: 16968502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onset of relief of symptoms of gastroesophageal reflux disease: post hoc analysis of two previously published studies comparing pantoprazole 20 mg once daily with nizatidine or ranitidine 150 mg twice daily.
    Haag S; Holtmann G
    Clin Ther; 2010 Apr; 32(4):678-90. PubMed ID: 20435237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease.
    Bytzer P; Blum A; De Herdt D; Dubois D;
    Aliment Pharmacol Ther; 2004 Jul; 20(2):181-8. PubMed ID: 15233698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pantoprazole versus lansoprazole in French patients with reflux esophagitis.
    Dupas JL; Houcke P; Samoyeau R;
    Gastroenterol Clin Biol; 2001 Mar; 25(3):245-50. PubMed ID: 11395670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esomeprazole versus pantoprazole for healing erosive oesophagitis.
    Vcev A; Begić I; Ostojić R; Jurcić D; Bozić D; Soldo I; Gmajnić R; Kondza G; Khaznadar E; Mićunović N
    Coll Antropol; 2006 Sep; 30(3):519-22. PubMed ID: 17058517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of erosive oesophagitis relapse with pantoprazole.
    Richter JE; Fraga P; Mack M; Sabesin SM; Bochenek W;
    Aliment Pharmacol Ther; 2004 Sep; 20(5):567-75. PubMed ID: 15339328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of efficacy of pantoprazole alone versus pantoprazole plus mosapride in therapy of gastroesophageal reflux disease: a randomized trial.
    Madan K; Ahuja V; Kashyap PC; Sharma MP
    Dis Esophagus; 2004; 17(4):274-8. PubMed ID: 15569362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter, randomized, double-blind study comparing 10, 20 and 40 mg pantoprazole in children (5-11 years) with symptomatic gastroesophageal reflux disease.
    Tolia V; Bishop PR; Tsou VM; Gremse D; Soffer EF; Comer GM;
    J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):384-91. PubMed ID: 16641576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparable efficacy of pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis. Results of a multinational study.
    Körner T; Schütze K; van Leendert RJ; Fumagalli I; Costa Neves B; Bohuschke M; Gatz G
    Digestion; 2003; 67(1-2):6-13. PubMed ID: 12743434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of pantoprazole in patients with gastroesophageal reflux disease using an intravenous-oral regimen. Austrian Intravenous Pantoprazole Study Group.
    Wurzer H; Schutze K; Bethke T; Fischer R; Luhmann R; Riesenhuber C
    Hepatogastroenterology; 1999; 46(27):1809-15. PubMed ID: 10430350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pantoprazole on-demand effectively treats symptoms in patients with gastro-oesophageal reflux disease.
    Scholten T; Teutsch I; Bohuschke M; Gatz G
    Clin Drug Investig; 2007; 27(4):287-96. PubMed ID: 17358101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel measurement of rapid treatment success with ReQuest: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole.
    Mönnikes H; Pfaffenberger B; Gatz G; Hein J; Bardhan KD
    Digestion; 2005; 71(3):152-8. PubMed ID: 15870503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis.
    Jaspersen D; Diehl KL; Schoeppner H; Geyer P; Martens E
    Aliment Pharmacol Ther; 1998 Jan; 12(1):49-52. PubMed ID: 9692700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of NSAID-associated gastrointestinal lesions: a comparison study pantoprazole versus omeprazole.
    Regula J; Butruk E; Dekkers CP; de Boer SY; Raps D; Simon L; Terjung A; Thomas KB; Lühmann R; Fischer R
    Am J Gastroenterol; 2006 Aug; 101(8):1747-55. PubMed ID: 16817839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.